These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 8190257)
1. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat. Banks RJ; Mozley L; Dourish CT Neuroscience; 1994 Feb; 58(4):799-805. PubMed ID: 8190257 [TBL] [Abstract][Full Text] [Related]
2. Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy. Stoessl AJ; Martin-Iverson MT; Barth TM; Dourish CT; Iversen SD Brain Res; 1989 Aug; 495(1):20-30. PubMed ID: 2570627 [TBL] [Abstract][Full Text] [Related]
3. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats]. Minematsu N Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718 [TBL] [Abstract][Full Text] [Related]
4. The preventive effect of captopril or enalapril on reperfusion injury of the kidney of rats is independent of angiotensin II AT1 receptors. Pazoki-Toroudi HR; Hesami A; Vahidi S; Sahebjam F; Seifi B; Djahanguiri B Fundam Clin Pharmacol; 2003 Oct; 17(5):595-8. PubMed ID: 14703720 [TBL] [Abstract][Full Text] [Related]
5. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
6. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril. Essig J; Belz GG; Wellstein A Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551 [TBL] [Abstract][Full Text] [Related]
7. Independent effects of morphine and apomorphine on stereotyped gnawing in the hamster. Schnur P; Martinez RA Pharmacol Biochem Behav; 1989 Mar; 32(3):589-94. PubMed ID: 2662220 [TBL] [Abstract][Full Text] [Related]
8. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice. Liu YH; Liu LY; Wu JX; Chen SX; Sun YX J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790 [TBL] [Abstract][Full Text] [Related]
9. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril. Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590 [TBL] [Abstract][Full Text] [Related]
10. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498. van Gilst WH; de Graeff PA; Wesseling H; de Langen CD J Cardiovasc Pharmacol; 1986; 8(4):722-8. PubMed ID: 2427810 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats. Okuyama S; Shimamura H; Hashimoto S; Aihara H Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410 [TBL] [Abstract][Full Text] [Related]
12. Distribution of Fos-immunoreactivity in rat brain following a dipsogenic dose of captopril and effects of angiotensin receptor blockade. McKinley MJ; Colvill LM; Giles ME; Oldfield BJ Brain Res; 1997 Jan; 747(1):43-51. PubMed ID: 9042526 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen. Männistö TK; Karvonen KE; Kerola TV; Ryhänen LJ J Hypertens; 2001 Oct; 19(10):1835-9. PubMed ID: 11593104 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats. Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats. Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254 [TBL] [Abstract][Full Text] [Related]
16. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats. Longoni R; Spina L; Di Chiara G Life Sci; 1987 Nov; 41(18):2135-45. PubMed ID: 2959833 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review. Kubo SH; Cody RJ Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of captopril and enalapril in obese Zucker rats. Duarte J; Martinez A; Bermejo A; Vera B; Gámez MJ; Cabo P; Zarzuelo A Eur J Pharmacol; 1999 Jan; 365(2-3):225-32. PubMed ID: 9988106 [TBL] [Abstract][Full Text] [Related]
20. Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats. Abd El-Aziz MA; Othman AI; Amer M; El-Missiry MA J Appl Toxicol; 2001; 21(6):469-73. PubMed ID: 11746193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]